TORADOL bulk active fine chemical vendors

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich	⤷ Get Started Free	K1136_SIGMA	⤷ Get Started Free
Molport	⤷ Get Started Free	MolPort-003-666-507	⤷ Get Started Free
Amadis Chemical	⤷ Get Started Free	A838011	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 2, 2025

Introduction

Ketorolac Tromethamine, marketed under the brand name Toradol, is a potent nonsteroidal anti-inflammatory drug (NSAID) primarily utilized for short-term management of moderate to severe acute pain. Its efficacy hinges on the quality and sourcing of the bulk Active Pharmaceutical Ingredient (API), which underpins drug safety, regulatory compliance, and supply chain resilience. This article offers an in-depth analysis of the global API sourcing landscape for ketorolac tromethamine, emphasizing market dynamics, key manufacturers, geographic distribution, quality standards, and strategic considerations for pharmaceutical companies.

Overview of Ketorolac Tromethamine API Market

The API market for ketorolac tromethamine is relatively concentrated, with a handful of manufacturers dominating production due to the complexity of synthesis, regulatory hurdles, and quality assurance. Given its critical role in pain management, pharmaceutical companies seek reliable, high-quality bulk API sources that adhere to stringent GMP standards, ensure seamless regulatory approval, and support large-scale manufacturing.

The global API market is driven by increasing global healthcare expenditure, expanding indications for NSAIDs, and the rising demand for effective analgesics. However, supply chain disruptions and regulatory challenges, particularly in ensuring purity, stability, and compliance, impact sourcing strategies.

Major API Manufacturers of Ketorolac Tromethamine

1. Miles Scientific LLC

Overview: Miles Scientific has established itself as a significant API manufacturer, offering ketorolac tromethamine with compliance to international GMP standards.
Capacity & Quality: Known for high-purity batches, consistent quality, and certification supporting regulatory submissions.
Regulatory Approvals: Their API is registered or approved in several markets, including the US, Europe, and Asia.

2. Wintam Fine Chemicals

Overview: Wintam specializes in synthetic NSAID APIs, with ketorolac tromethamine as a flagship product.
Manufacturing: Their manufacturing process adheres to cGMP standards; they cater predominantly to OEM clients and large-scale API buyers.
Quality Assurance: Extensive stability, purity testing, and transparency support regulatory processes.

3. Zhejiang Hisun Pharmaceuticals

Overview: A vertically integrated pharmaceutical company based in China with significant API manufacturing expertise.
Production Capabilities: Possesses large-scale facilities capable of supplying high-volume orders.
Standards: Compliant with both Chinese GMP and international standards, facilitating exports globally.

4. Synthon

Overview: A Dutch-based company with comprehensive API production capabilities.
Focus: Partners with various pharmaceutical firms to supply high-quality NSAIDs, including ketorolac tromethamine.
Regulatory Compliance: Emphasizes strict adherence to EU GMP standards.

5. Zhejing Tianyu Pharmaceutical Co., Ltd.

Overview: Chinese manufacturer focused on NSAID APIs.
Market Position: Provides cost-effective solutions for generic drug manufacturers.
Standards: Varies across facilities but increasingly aligning with global GMP standards.

Geographic Distribution of Source Countries

China

China remains the dominant global supplier of ketorolac tromethamine API due to its large-scale manufacturing facilities, cost advantages, and rapid product development cycles. Chinese API producers often obtain certifications such as Chinese GMP, with many achieving auditable compliance with international standards to facilitate exports.

India

India offers an alternative source, with several API manufacturers capable of producing high-quality ketorolac tromethamine. Indian companies benefit from robust domestic regulation frameworks, with many achieving US FDA approval for their facilities, thus easing export to regulated markets.

Europe

European manufacturers, primarily led by companies like Synthon, focus on high-quality APIs compliant with strict GMP standards. Although production costs are higher, their reputation for consistency and regulatory confidence makes European APIs attractive for sensitive applications.

United States

While the US API market tends to rely on imported APIs, domestic manufacturing exists, often aligned with stringent FDA regulations. However, US manufacturing capacity for ketorolac tromethamine remains limited relative to China and India.

Quality and Regulatory Compliance

API sourcing for ketorolac tromethamine mandates strict adherence to quality standards:

GMP Compliance: Essential for ensuring batch-to-batch consistency, potency, and safety.
Pharmacopoeia Standards: API manufacturers must meet specifications outlined in pharmacopeias such as USP, EP, or JP.
Certificates of Analysis (CoA): Should demonstrate high purity (>99%), low residual solvents, and absence of heavy metals.
Regulatory approvals: For market authorization, APIs used in finished products should have requisite certifications, including WHO-GMP, US FDA, EMA, or ISO standards.

Lapses in quality assurance can lead to batch failures, regulatory delays, or product recalls, emphasizing the importance of selecting reputable suppliers.

Strategic Factors in API Sourcing for Toradol

1. Reliability of Supply

Given the critical role of ketorolac tromethamine in pain management therapies, supply chain resilience is vital. Diversification of sources, including dual or multiple suppliers, diminishes risks associated with geopolitical tensions, factory shutdowns, or raw material shortages.

2. Cost Considerations

Price competitiveness is influential, with Chinese and Indian manufacturers offering cost advantages. However, lower costs must be balanced against regulatory acceptability and quality integrity.

3. Lead Times

Manufacturers with well-established logistics networks and large-scale capacity can meet tight production schedules, minimizing market disruptions.

4. Regulatory Track Record

Suppliers with proven compliance histories enhance effortless approval procedures and reduce regulatory scrutiny on finished products.

5. Sustainability and Ethical Sourcing

Increasingly, pharmaceutical companies prioritize vendors committed to responsible manufacturing practices, environmental sustainability, and ethical labor standards.

Emerging Trends and Future Outlook

Investment in Biocatalysis: Some manufacturers explore greener and more efficient synthesis methods, including biocatalytic processes, to improve purity and reduce environmental impact.
GMP Upgrades and Certification: Continuous modernization aligns Chinese and Indian facilities with international GMP standards, broadening global acceptance.
Digital Supply Chain Integration: Use of blockchain and advanced tracking enhances transparency and traceability in API sourcing.
Regional Diversification: To mitigate geopolitical risks and avoid over-reliance on specific regions, sourcing strategies are increasingly diversified across Asia, Europe, and the US.

Conclusion

The sourcing landscape for ketorolac tromethamine API intertwines quality, cost, regulatory compliance, and supply chain resilience. Leading manufacturers, primarily based in China and India, continue to dominate, supported by their scalable manufacturing infrastructure and evolving compliance standards. Multinational pharmaceutical companies must perform rigorous due diligence, considering supplier certifications, quality assurance protocols, and geopolitical stability when establishing or renewing API supply agreements. Strategic sourcing integrated with proactive quality management and diversification safeguards ensures consistent supply, regulatory compliance, and the continued availability of Toradol for patients in need.

Key Takeaways

Diversify suppliers to mitigate risks related to geopolitical issues, quality variability, or supply disruptions.
Prioritize vendors with robust GMP certifications, proven regulatory track records, and transparent testing data.
Balance cost with quality, understanding that lower prices may entail trade-offs in compliance and purity.
Monitor emerging trends, including greener synthesis methods and digital supply chain solutions, for long-term sourcing resilience.
Establish long-term partnerships with reputable manufacturers to ensure supply stability and regulatory alignment.

FAQs

1. Which countries are the primary sources of ketorolac tromethamine API?
China and India are the leading global suppliers, offering high-volume production at competitive prices. European manufacturers like Synthon also supply high-quality APIs for regulated markets.

2. How can buyers verify the quality of API suppliers for Toradol?
Verify GMP certifications, review Certificates of Analysis, evaluate regulatory approvals, conduct audits if possible, and assess compliance history with pharmacopoeia standards.

3. What are the regulatory considerations when sourcing ketorolac tromethamine APIs?
APIs must meet GMP standards, adhere to USP, EP, or JP monographs, and possess necessary certifications for market approval in target regions.

4. What risks are associated with relying solely on Chinese APIs for Toradol?
Risks include geopolitical tensions, quality variability, regulatory changes, and supply chain disruptions. Diversification reduces vulnerability.

5. How is the trend towards sustainable manufacturing influencing API sourcing?
Manufacturers adopting environmentally friendly processes, such as biocatalysis and green chemistry, are increasingly preferred, aligning supply chains with sustainability commitments and regulatory expectations.

References

[1] MarketWatch. Global NSAID API Market Analysis, 2022.
[2] U.S. Pharmacopeia. Standards for Ketorolac Tromethamine API, 2021.
[3] European Medicines Agency. Guidelines on Manufacturing Quality, 2022.
[4] China Food and Drug Administration (CFDA). API Certification Standards, 2022.
[5] Indian Pharmacopoeia Commission. Pharmaceutical Standards for NSAID APIs, 2022.

Bulk Pharmaceutical API Sources for TORADOL